Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Merola

Showing results (211-220 of 442) with videos related to

Pageof 45
Sort By:
Journal of Psoriasis and Psoriatic Arthritis|May 5, 2026
Safety of IL-17A Inhibitors in Patients With Moderate to Severe Psoriasis in a US Claims Data-Based Cohort StudyMaria C Schneeweiss, Joseph F Merola, Yinzhu Jin, et al.
Dermatology and Therapy|July 14, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 TrialsRichard B Warren, Alice B Gottlieb, Joseph F Merola, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
The International Dermatology Outcome Measures (IDEOM) Initiative: A Review and UpdateScott A Elman, Joseph F Merola, April W Armstrong, et al.
The Journal of Dermatological Treatment|March 8, 2021
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasisSteven R Feldman, Joseph F Merola, David M Pariser, et al.
Journal of the American Academy of Dermatology|August 21, 2023
Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: A US nationwide cohort studyMaria C Schneeweiss, Richard Wyss, Sebastian Schneeweiss, et al.
Dermatology and Therapy|May 14, 2023
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT SurveyJoseph F Merola, Alexis Ogdie, Alice B Gottlieb, et al.
Lab on a Chip|January 28, 2014
Particle tracking by full-field complex wavefront subtraction in digital holography microscopyL Miccio, P Memmolo, F Merola, et al.
The Journal of Rheumatology|August 5, 2025
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual MeetingSarah Romanelli, Beth Childs, Vibeke Strand, et al.
Nature Reviews. Disease Primers|June 26, 2025
PsoriasisApril W Armstrong, Andrew Blauvelt, Kristina Callis Duffin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 15, 2022
Effects of risankizumab on nail psoriasis in patients with active psoriatic arthritis: results from KEEPsAKE 1L E Kristensen, A M Soliman, K Papp, et al.
Pageof 45

Showing results (211-220 of 442) with videos related to

Sort By:
Pageof 45
Journal of Psoriasis and Psoriatic Arthritis|May 5, 2026
Safety of IL-17A Inhibitors in Patients With Moderate to Severe Psoriasis in a US Claims Data-Based Cohort StudyMaria C Schneeweiss, Joseph F Merola, Yinzhu Jin, et al.
Dermatology and Therapy|July 14, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 TrialsRichard B Warren, Alice B Gottlieb, Joseph F Merola, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
The International Dermatology Outcome Measures (IDEOM) Initiative: A Review and UpdateScott A Elman, Joseph F Merola, April W Armstrong, et al.
The Journal of Dermatological Treatment|March 8, 2021
Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasisSteven R Feldman, Joseph F Merola, David M Pariser, et al.
Journal of the American Academy of Dermatology|August 21, 2023
Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: A US nationwide cohort studyMaria C Schneeweiss, Richard Wyss, Sebastian Schneeweiss, et al.
Dermatology and Therapy|May 14, 2023
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT SurveyJoseph F Merola, Alexis Ogdie, Alice B Gottlieb, et al.
Lab on a Chip|January 28, 2014
Particle tracking by full-field complex wavefront subtraction in digital holography microscopyL Miccio, P Memmolo, F Merola, et al.
The Journal of Rheumatology|August 5, 2025
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual MeetingSarah Romanelli, Beth Childs, Vibeke Strand, et al.
Nature Reviews. Disease Primers|June 26, 2025
PsoriasisApril W Armstrong, Andrew Blauvelt, Kristina Callis Duffin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 15, 2022
Effects of risankizumab on nail psoriasis in patients with active psoriatic arthritis: results from KEEPsAKE 1L E Kristensen, A M Soliman, K Papp, et al.
Pageof 45